Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts Deep Space Energy Secures US$1.1 Million to Advance Lunar Power and Satellite Resilience Goals February 13, 2026 The True Value of Olympic Gold: Beyond Metal and Market Prices February 13, 2026 Binding Option to Acquire 90% of Advanced Pomme REE Project in Quebec, Partnering with Metallium February 13, 2026
Deep Space Energy Secures US$1.1 Million to Advance Lunar Power and Satellite Resilience Goals February 13, 2026
Binding Option to Acquire 90% of Advanced Pomme REE Project in Quebec, Partnering with Metallium February 13, 2026